“Where Purpose Meets Progress – accelerating progress for Leiomyosarcoma research, through advancing collaborative priorities of the research community and the patient communities served by the NLMSF.”
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients—A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)
Principle Author: Bernd Kasper, MD, PhD
Professor, Univeritalsmedizin Mannheim
NLMSF - SPAEN Executive Committee / International LMS Research Roundtable Steering Committee
What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?
COMPREHENSIVE RESEARCH PUBLICATIONS ON LEIOMYOSARCOMA:
- A comprehensive Research Paper guided by Dr. Rebecca Gladdy,Sarcoma Research Clinician/Surgeon, Mt .Sinai Hospital, Toronto. Esteemed member of the NLMSF-SPAEN International LMS Research Roundtable. This publication is yet another compass for the Roundtable focus workgroups: Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival https://www.nature.com/articles/s41467-021-24677-6
General sarcoma information
Scott Okuno, MD Professor of Oncology Mayo Clinic Rochester, MN
Dr Seth Pollack, MD Director of the Sarcoma Program at the Lurie Cancer Center ROBERT H. LURIE COMPREHENSIVE CANCER CENTER OF NORTHWESTERN UNIVERSITY
Arun Singh, M.D. Associate Professor Sarcoma Service Division of Hematology-Oncology, U.C.L.A.
THE UNIVERSITY OF MICHIGAN TO LEAD MULTI-SITE $12M GRANT TO STUDY RARE TYPE OF SARCOMA
"Paying it Forward to the LMS Community in partnership with the Research Community"